Anika Therapeutics ANIK
NASDAQ ANIK
$21.40 +0.14 (+0.66%)
At close: Aug 20, 2026 · 12:31 PM UTC

Anika Therapeutics (ANIK) Non-Current Debt (2010 - 2020)

Anika Therapeutics (ANIK) posted quarterly Non-Current Debt of $25.0 million for Q3 2020, down 50.0% quarter-over-quarter from $50.0 million in Q2 2020.

Anika Therapeutics (ANIK) Non-Current Debt (2010 - 2020) Analysis & Trends

Anika Therapeutics (ANIK) has reported Non-Current Debt for 5 consecutive years, with $25.0 million the latest figure, recorded in Q3 2020.

  • In Q3 2020, Non-Current Debt changed N/A year-over-year to $25.0 million; the TTM figure through Sep 2020 stood at $25.0 million (changed N/A YoY), while the FY2012 annual figure was $9.6 million, down 14.29% from the prior year.
  • Non-Current Debt slipped to $25.0 million in Q3 2020 per ANIK's latest filing, from $50.0 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $50.0 million in Q2 2020 and bottomed at $25.0 million in Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Haleon 43.98 Bn 43.02 Bn - -8.44 Bn
2 Teva Pharmaceutical Industries 43.28 Bn 39.62 Bn 2.15 Bn 12.09 Bn
3 Zoetis 31.79 Bn 30.11 Bn 1.05 Bn 9.05 Bn
4 Takeda Pharmaceutical 28.69 Bn 22.89 Bn 5.10 Bn 27.73 Bn
5 United Therapeutics 22.25 Bn 19.58 Bn 683.80 Mn -
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn 11.61 Bn
7 Neurocrine Biosciences 15.58 Bn 15.19 Bn 935.80 Mn -
8 Elanco Animal Health 11.87 Bn 11.34 Bn 798.00 Mn 3.85 Bn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - 130.00 Mn
10 Anika Therapeutics 285.26 Mn 246.85 Mn 21.24 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2020 25.00 Mn
Jun 30, 2020 50.00 Mn
Sep 30, 2013 8.40 Mn
Jun 30, 2013 8.80 Mn
Mar 31, 2013 9.20 Mn
Dec 31, 2012 9.60 Mn
Sep 30, 2012 10.00 Mn
Jun 30, 2012 10.40 Mn
Mar 31, 2012 9.20 Mn
Dec 31, 2011 11.20 Mn
Sep 30, 2011 10.00 Mn
Jun 30, 2011 10.40 Mn
Dec 31, 2010 11.20 Mn